Abstract:The circadian clocks communicating tumour immune microenvironment (TIME) and the immunogenicity of colorectal cancer (CRC) cells. The TIME and immunogenicity of CRC cells are time‐dependent. TIME: the circadian clocks regulate the infiltration and function of Th 17, Treg cells, CD8 + T cells and tumour associated macrophages (TAMs). Tumour‐associated fibroblasts (CAFs) affect the recruitment of immune cells in TIME by secretion of growth factors, cytokines and chemokines, serving as its role in molecular circadian clockwork. The immunogenicity of CRC cell: the circadian clocks influence the microsatellite instability (MSI) status, tumour mutation burden (TMB) and the expression of PD‐L1 of CRC cells, thus changing the immunogenicity of CRC cells. Therefore, circadian clocks could influence responses to anti‐programmed death‐1 therapy by regulating the two important sides. The clock‐targeting drugs (RORα agonist and RORγ agonist) could enhance the efficacy of immune checkpoint inhibitor therapy by regulating the TIME. (Arrows represent positive or upregulated relationships; flat connectors represent negative or inhibitory relationships. TIME means both tumour immune microenvironment and time.) Colorectal cancer (CRC) is one of the most common malignant tumours and the third most common cause of cancer deaths worldwide, with high morbidity and mortality. Circadian clocks are widespread in humans and temporally regulate physiologic functions to maintain homeostasis. Recent studies showed that circadian components were strong regulators of the tumour immune microenvironment (TIME) and the immunogenicity of CRC cells. Therefore, insight into immunotherapy from the perspective of circadian clocks can be promising. Although immunotherapy, especially immune checkpoint inhibitor (ICI) treatment, has been a milestone in cancer treatment, greater accuracy is still needed for selecting patients who will respond positively to immunotherapy with minimal side effects. In addition, there were few reviews focusing on the role of the circadian components in the TIME and the immunogenicity of CRC cells. Therefore, this review highlights the crosstalk between the TIME in CRC and the immunogenicity of CRC cells based on the circadian clocks. With the goal to achieve the possibility that patients with CRC can benefit most from the ICI treatment, we provide potential evidence and a novel idea for building a predictive framework combined with circadian factors, searching for enhancers of ICIs targeting circadian components and clinically implementing the timing of ICI treatment for patients with CRC.

The genomic and transcriptomic landscapes of clock genes reveal the significance of circadian rhythm in the progression and immune microenvironment of metastatic colorectal cancer

Dysfunctional circadian clock accelerates cancer metastasis by intestinal microbiota triggering accumulation of myeloid-derived suppressor cells

Upregulation of Circadian Gene 'hclock' Contribution to Metastasis of Colorectal Cancer

Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses

The Role of Circadian Rhythm in the Pathogenesis of Colorectal Cancer

Circadian rhythm-associated clinical relevance and Tumor Microenvironment of Non-small Cell Lung Cancer

Circadian rhythm regulates the function of immune cells and participates in the development of tumors

Genetic Landscapes and Prognostic Implications of Circadian Rhythm in Non-small Cell Lung Cancer

Identification of potential circadian genes and associated pathways in colorectal cancer progression and prognosis using microarray gene expression analysis

Dysregulation of Circadian Clock Genes Associated with Tumor Immunity and Prognosis in Patients with Colon Cancer

Circadian disruption in cancer hallmarks: Novel insight into the molecular mechanisms of tumorigenesis and cancer treatment

Circadian clock associates with tumor microenvironment in thoracic cancers

Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapy

Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade

Insight into immune checkpoint inhibitor therapy for colorectal cancer from the perspective of circadian clocks

Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy

Circadian Gene Hclock Contributes To Progression Of Colorectal Carcinoma And Is Directly Regulated By Tumor-Suppressive Microrna-124

Circadian rhythms and breast cancer: unraveling the biological clock's role in tumor microenvironment and ageing

CBX4 Provides an Alternate Mode of Colon Cancer Development <i>via</i> Potential Influences on Circadian Rhythm and Immune Infiltration

CBX4 Provides an Alternate Mode of Colon Cancer Development via Potential Influences on Circadian Rhythm and Immune Infiltration

Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation